Journal of Internal Medicine Concepts & Practice ›› 2022, Vol. 17 ›› Issue (05): 405-407.doi: 10.16138/j.1673-6087.2022.05.012
• Review article • Previous Articles Next Articles
HU Jielinga, LIU Tongjuna, LIANG Weib(
)
Received:2021-07-28
Online:2022-09-30
Published:2022-11-04
Contact:
LIANG Wei
E-mail:lw10920@rjh.com.cn
CLC Number:
HU Jieling, LIU Tongjun, LIANG Wei. Research progress of senile sarcopenia with cardiac insufficiency[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 405-407.
| [1] |
Rosenberg IH. Sarcopenia: origins and clinical relevance[J]. J Nutr, 1997, 127(5 Suppl): 990S-991S.
doi: 10.1093/jn/127.5.990S URL |
| [2] | 姜珊, 康琳, 刘晓红. 2019亚洲肌少症诊断及治疗共识解读[J]. 中华老年医学杂志, 2020, 39(4): 373-376. |
| [3] |
Cruz-Jentoft AJ, Landi F, Topinková E, et al. Understanding sarcopenia as a geriatric syndrome[J]. Curr Opin Clin Nutr Metab Care, 2010, 13(1): 1-7.
doi: 10.1097/MCO.0b013e328333c1c1 URL |
| [4] | 俞锋, 贾敏江. 心功能不全诊治的新进展[J]. 心脏杂志, 2000, 12(1): 34-37. |
| [5] | 黄峻. 盘点2016年心力衰竭临床研究进展[J]. 中华心力衰竭和心肌病杂志(中英文), 2017, 1(1): 42-47. |
| [6] | 贾新菊. 射血分数正常的心力衰竭患者研究[J]. 心血管病防治知识, 2019, 9(15): 37-39. |
| [7] |
von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact[J]. J Cachexia Sarcopenia Muscle, 2010, 1(2): 129-133.
pmid: 21475695 |
| [8] |
von Haehling S. The wasting continuum in heart failure: from sarcopenia to cachexia[J]. Proc Nutr Soc, 2015, 74(4): 367-377.
doi: 10.1017/S0029665115002438 pmid: 26264581 |
| [9] | 吴琳瑾, 李静欣. 中国社区老年人肌少症患病率的Meta分析[J]. 现代预防医学, 2019, 46(22): 4109-4112. |
| [10] | 刘嘉璐, 蔡雨阳. 上海市社区老年人肌少症的调查结果以及特点研究[J]. 健康大视野, 2019, 18: 248-249. |
| [11] |
Fülster S, Tacke M, Sandek A, et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)[J]. Eur Heart J, 2013, 34(7): 512-519.
doi: 10.1093/eurheartj/ehs381 pmid: 23178647 |
| [12] | 蒋庆庆, 戴朝晖, 段娟, 等. 老年患者肌少症与慢性心力衰竭相关性的临床研究[J]. 中华老年医学杂志, 2020, 39(2): 147-150. |
| [13] | 信栓力, 焦凤辉, 常超, 等. 肌少症对老年慢性心力衰竭患者骨骼肌及心功能的影响[J]. 中华全科医师杂志, 2019, 18(8): 751-755. |
| [14] | 肖潇, 胡松, 赵婷, 等. 肌少症对老年慢性心力衰竭患者肌力和活动能力的影响[J]. 中华全科医师杂志, 2019, 18(4): 343-346. |
| [15] | 胡正光, 赵雯娟, 曹晓霞, 等. 肌少症对老年射血分数保留心力衰竭患者中期预后影响的研究[J]. 中国心血管杂志, 2020, 25(6): 547-550. |
| [16] |
Tsuchida K, Fujihara Y, Hiroki J, et al. Significance of sarcopenia evaluation in acute decompensated heart failure[J]. Int Heart J, 2018, 59(1): 143-148.
doi: 10.1536/ihj.17-057 pmid: 29332917 |
| [17] |
Onoue Y, Izumiya Y, Hanatani S, et al. A simple sarcopenia screening test predicts future adverse events in patients with heart failure[J]. Int J Cardiol, 2016, 215: 301-306.
doi: 10.1016/j.ijcard.2016.04.128 pmid: 27128551 |
| [18] |
Iwakami N, Nagai T, Furukawa TA, et al. Prognostic value of malnutrition assessed by controlling nutritional status score for long-term mortality in patients with acute heart failure[J]. Int J Cardiol, 2017, 230: 529-536.
doi: S0167-5273(16)34552-1 pmid: 28041709 |
| [19] |
Can B, Kara O, Kizilarslanoglu MC, et al. Serum markers of inflammation and oxidative stress in sarcopenia[J]. Aging Clin Exp Res, 2017, 29(4): 745-752.
doi: 10.1007/s40520-016-0626-2 pmid: 27571781 |
| [20] | Saitoh M, Dos Santos MR, Emami A, et al. Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure(SICA-HF)[J]. ESC Heart Fail, 2017, 4(4): 448-457. |
| [21] |
Wong A, Frishman W. Sarcopenia and cardiac dysfunction[J]. Cardiol Rev, 2020, 28(4): 197-202.
doi: 10.1097/CRD.0000000000000285 pmid: 31868771 |
| [22] |
Morley JE. Anorexia of ageing: a key component in the pathogenesis of both sarcopenia and cachexia[J]. J Cachexia Sarcopenia Muscle, 2017, 8(4): 523-526.
doi: 10.1002/jcsm.12192 pmid: 28452130 |
| [23] |
Bano G, Trevisan C, Carraro S, et al. Inflammation and sarcopenia: a systematic review and meta-analysis[J]. Maturitas, 2017, 96: 10-15.
doi: S0378-5122(16)30342-5 pmid: 28041587 |
| [24] |
Fonseca GWPD, Santos MRD, Souza FR, et al. Sympatho-vagal imbalance is associated with sarcopenia in male patients with heart failure[J]. Arq Bras Cardiol, 2019, 112(6): 739-746.
doi: S0066-782X2019000600739 pmid: 30970141 |
| [25] |
Bielecka-Dabrowa A, Ebner N, Dos Santos MR, et al. Cachexia, muscle wasting, and frailty in cardiovascular disease[J]. Eur J Heart Fail, 2020, 22(12): 2314-2326.
doi: 10.1002/ejhf.2011 URL |
| [26] |
Springer J, Springer JI, Anker SD. Muscle wasting and sarcopenia in heart failure and beyond[J]. ESC Heart Fail, 2017, 4(4): 492-498.
doi: 10.1002/ehf2.12237 pmid: 29154428 |
| [27] |
Tanaka K, Valero-Muñoz M, Wilson RM, et al. Follistatin like 1 regulates hypertrophy in heart failure with preserved ejection fraction[J]. JACC Basic Transl Sci, 2016, 1(4): 207-221.
doi: 10.1016/j.jacbts.2016.04.002 pmid: 27430031 |
| [28] |
Sundaresan NR, Bindu S, Pillai VB, et al. SIRT3 blocks aging-associated tissue fibrosis in mice by deacetylating and activating glycogen synthase kinase 3β[J]. Mol Cell Biol, 2015, 36(5): 678-692.
doi: 10.1128/MCB.00586-15 pmid: 26667039 |
| [29] | 张音, 沈宏华, 许轶明, 等. 肌少症的诊断与治疗研究进展[J]. 内科理论与实践, 2021, 16(3): 220-224. |
| [30] |
Calvani R, Marini F, Cesari M, et al. Systemic inflammation, body composition, and physical performance in old community-dwellers[J]. J Cachexia Sarcopenia Muscle, 2017, 8(1): 69-77.
doi: 10.1002/jcsm.12134 pmid: 27897412 |
| [31] |
Webster JM, Kempen LJAP, Hardy RS, et al. Inflammation and skeletal muscle wasting during cachexia[J]. Front Physiol, 2020, 11: 597675.
doi: 10.3389/fphys.2020.597675 URL |
| [32] |
Dirks AJ, Leeuwenburgh C. Tumor necrosis factor alpha signaling in skeletal muscle[J]. J Nutr Biochem, 2006, 17(8): 501-508.
pmid: 16517142 |
| [33] |
Oshima Y, Ouchi N, Sato K, et al. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart[J]. Circulation, 2008, 117(24): 3099-3108.
doi: 10.1161/CIRCULATIONAHA.108.767673 pmid: 18519848 |
| [34] |
Mattiotti A, Prakash S, Barnett P, et al. Follistatin-like 1 in development and human diseases[J]. Cell Mol Life Sci, 2018, 75(13): 2339-2354.
doi: 10.1007/s00018-018-2805-0 pmid: 29594389 |
| [35] |
Tsuda M, Fukushima A, Matsumoto J, et al. Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure[J]. J Cachexia Sarcopenia Muscle, 2018, 9(5): 844-859.
doi: 10.1002/jcsm.12322 pmid: 30168279 |
| [36] |
Zhang J, Xiang H, Liu J, et al. Mitochondrial sirtuin 3: new emerging biological function and therapeutic target[J]. Theranostics, 2020, 10(18): 8315-8342.
doi: 10.7150/thno.45922 pmid: 32724473 |
| [37] |
Parodi-Rullán RM, Chapa-Dubocq XR, Javadov S. Acetylation of mitochondrial proteins in the heart[J]. Front Physiol, 2018, 9: 1094.
doi: 10.3389/fphys.2018.01094 pmid: 30131726 |
| [38] |
St-Jean-Pelletier F, Pion CH, Leduc-Gaudet JP, et al. The impact of ageing, physical activity, and pre-frailty on skeletal muscle phenotype, mitochondrial content, and intramyocellular lipids in men[J]. J Cachexia Sarcopenia Muscle, 2017, 8(2): 213-228.
doi: 10.1002/jcsm.12139 pmid: 27897402 |
| [39] |
Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities[J]. J Endocrinol, 2016, 229(2): R67-R81.
doi: 10.1530/JOE-15-0533 URL |
| [40] |
Hong SH, Choi KM. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences[J]. Int J Mol Sci, 2020, 21(2): 494.
doi: 10.3390/ijms21020494 URL |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
